rs112176097

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001352514.2(HLCS):​c.914C>T​(p.Thr305Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000483 in 1,614,110 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T305T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0023 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00029 ( 0 hom. )

Consequence

HLCS
NM_001352514.2 missense

Scores

2
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.540

Publications

3 publications found
Variant links:
Genes affected
HLCS (HGNC:4976): (holocarboxylase synthetase) This gene encodes an enzyme that catalyzes the binding of biotin to carboxylases and histones. The protein plays an important role in gluconeogenesis, fatty acid synthesis and branched chain amino acid catabolism. Defects in this gene are the cause of holocarboxylase synthetase deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Jun 2011]
HLCS Gene-Disease associations (from GenCC):
  • holocarboxylase synthetase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0069985986).
BP6
Variant 21-36936972-G-A is Benign according to our data. Variant chr21-36936972-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 203760.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00231 (351/152226) while in subpopulation AFR AF = 0.00811 (337/41558). AF 95% confidence interval is 0.0074. There are 3 homozygotes in GnomAd4. There are 164 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HLCSNM_001352514.2 linkc.914C>T p.Thr305Met missense_variant Exon 4 of 11 ENST00000674895.3 NP_001339443.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HLCSENST00000674895.3 linkc.914C>T p.Thr305Met missense_variant Exon 4 of 11 NM_001352514.2 ENSP00000502087.2 P50747-2A0A8C8QSB1

Frequencies

GnomAD3 genomes
AF:
0.00226
AC:
344
AN:
152108
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00794
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000672
AC:
169
AN:
251388
AF XY:
0.000552
show subpopulations
Gnomad AFR exome
AF:
0.00868
Gnomad AMR exome
AF:
0.000347
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000880
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000293
AC:
429
AN:
1461884
Hom.:
0
Cov.:
34
AF XY:
0.000271
AC XY:
197
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.00735
AC:
246
AN:
33480
American (AMR)
AF:
0.000805
AC:
36
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.000116
AC:
10
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000854
AC:
95
AN:
1112010
Other (OTH)
AF:
0.000563
AC:
34
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
32
64
97
129
161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00231
AC:
351
AN:
152226
Hom.:
3
Cov.:
32
AF XY:
0.00220
AC XY:
164
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.00811
AC:
337
AN:
41558
American (AMR)
AF:
0.000523
AC:
8
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68006
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
14
28
42
56
70
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00101
Hom.:
0
Bravo
AF:
0.00265
ESP6500AA
AF:
0.00794
AC:
35
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000832
AC:
101
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000356

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Holocarboxylase synthetase deficiency Benign:2
Dec 13, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 16, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26334177) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
9.9
DANN
Benign
0.93
DEOGEN2
Benign
0.18
T;T;T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.21
N
LIST_S2
Uncertain
0.88
D;.;.
M_CAP
Benign
0.054
D
MetaRNN
Benign
0.0070
T;T;T
MetaSVM
Uncertain
0.14
D
MutationAssessor
Benign
1.0
L;L;L
PhyloP100
0.54
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.42
.;N;N
REVEL
Benign
0.17
Sift
Benign
0.21
.;T;T
Sift4G
Benign
0.094
T;T;T
Polyphen
0.068
B;B;B
Vest4
0.12
MVP
0.84
MPC
0.13
ClinPred
0.0020
T
GERP RS
-2.0
Varity_R
0.019
gMVP
0.27
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs112176097; hg19: chr21-38309272; API